Abstract
Arsenic is either notorious toxicant or miracle cure for acute promyelocytic leukemia and several other diseases. It interacts with mitochondria directly or indirectly, by interacting with mitochondrial enzymes, such as respiratory chain complexes and tricarboxylic acid cycle proteins, or affecting mitochondrial homeostasis via ROS or mitochondrial outer membrane permeabilization. Given the ubiquitous presence of mitochondria and indispensable role in cellular metabolism, arsenical-mitochondrial interactions may manifest clinical importance by revealing mechanism of disease curation, preventing severe side effects, and foreseeing potential health issues. Here, we described the interaction between isolated mitochondria and arsenicals.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Sharma VK, Sohn M (2009) Aquatic arsenic: toxicity, speciation, transformations, and remediation. Environ Int 35(4):743–759. https://doi.org/10.1016/j.envint.2009.01.005
Tam LM, Price NE, Wang Y (2020) Molecular mechanisms of arsenic-induced disruption of DNA repair. Chem Res Toxicol 33(3):709–726. https://doi.org/10.1021/acs.chemrestox.9b00464
Mandal BK, Suzuki KT (2002) Arsenic round the world: a review. Talanta 58(1):201–235. https://doi.org/10.1016/S0039-9140(02)00268-0
Taylor V, Goodale B, Raab A, Schwerdtle T, Reimer K, Conklin S, Karagas MR, Francesconi KA (2017) Human exposure to organic arsenic species from seafood. Sci Total Environ 580:266–282. https://doi.org/10.1016/j.scitotenv.2016.12.113
Ali W, Zhang H, Junaid M, Mao K, Xu N, Chang C, Rasool A, Wajahat Aslam M, Ali J, Yang Z (2020) Insights into the mechanisms of arsenic-selenium interactions and the associated toxicity in plants, animals, and humans: a critical review. Crit Rev Environ Sci Technol 51(7):704–750. https://doi.org/10.1080/10643389.2020.1740042
Druwe IL, Vaillancourt RR (2010) Influence of arsenate and arsenite on signal transduction pathways: an update. Arch Toxicol 84(8):585–596. https://doi.org/10.1007/s00204-010-0554-4
Abernathy CO, Liu YP, Longfellow D, Aposhian HV, Beck B, Fowler B, Goyer R, Menzer R, Rossman T, Thompson C, Waalkes M (1999) Arsenic: health effects, mechanisms of actions, and research issues. Environ Health Perspect 107(7):593–597. https://doi.org/10.2307/3434403
Kumagai Y, Sumi D (2007) Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu Rev Pharmacol Toxicol 47(1):243–262. https://doi.org/10.1146/annurev.pharmtox.47.120505.105144
Zhu J, Chen Z, Lallemand-Breitenbach V, de The H (2002) How acute promyelocytic leukaemia revived arsenic. Nat Rev Cancer 2(9):705–714. https://doi.org/10.1038/nrc887
Diaz Z, Mann KK, Marcoux S, Kourelis M, Colombo M, Komarnitsky PB, Miller WH Jr (2008) A novel arsenical has antitumor activity toward As2O3-resistant and MRP1//ABCC1-overexpressing cell lines. Leukemia 22(10):1853–1863. https://doi.org/10.1038/leu.2008.328
Noguera NI, Piredda ML, Taulli R, Catalano G, Angelini G, Gaur G, Nervi C, Voso MT, Lunardi A, Pandolfi PP, Lo-Coco F (2016) PML/RARa inhibits PTEN expression in hematopoietic cells by competing with PU.1 transcriptional activity. Oncotarget 7(41):66386–66397. https://doi.org/10.18632/oncotarget.11964
Gibaud S, Jaouen G (2010) Arsenic-based drugs: from fowler’s solution to modern anticancer chemotherapy. In: Jaouen G, Metzler-Nolte N (eds) Medicinal organometallic chemistry. Springer, Berlin, pp 1–20. https://doi.org/10.1007/978-3-642-13185-1_1
Yang Z, Kang DH, Lee H, Shin J, Yan W, Rathore B, Kim H-R, Kim SJ, Singh H, Liu L, Qu J, Kang C, Kim JS (2018) A fluorescent probe for stimulated emission depletion super-resolution imaging of vicinal-dithiol-proteins on mitochondrial membrane. Bioconjug Chem 29(4):1446–1453. https://doi.org/10.1021/acs.bioconjchem.8b00128
Fan XY, Liu YJ, Chen K, Jiang FL, Hu YJ, Liu D, Liu Y, Ge YS (2018) Organic arsenicals target thioredoxin reductase followed by oxidative stress and mitochondrial dysfunction resulting in apoptosis. Eur J Med Chem 143:1090–1102. https://doi.org/10.1016/j.ejmech.2017.05.022
Liu Y, Duan D, Yao J, Zhang B, Peng S, Ma H, Song Y, Fang J (2014) Dithiaarsanes induce oxidative stress-mediated apoptosis in HL-60 cells by selectively targeting thioredoxin reductase. J Med Chem 57(12):5203–5211. https://doi.org/10.1021/jm500221p
Elliott MA, Ford SJ, Prasad E, Dick LJ, Farmer H, Hogg PJ, Halbert GW (2012) Pharmaceutical development of the novel arsenical based cancer therapeutic GSAO for phase I clinical trial. Int J Pharm 426(1):67–75. https://doi.org/10.1016/j.ijpharm.2012.01.024
Park D, Chiu J, Perrone GG, Dilda PJ, Hogg PJ (2012) The tumour metabolism inhibitors GSAO and PENAO react with cysteines 57 and 257 of mitochondrial adenine nucleotide translocase. Cancer Cell Int 12(1):11–16. https://doi.org/10.1186/1475-2867-12-11
Don AS, Kisker O, Dilda P, Donoghue N, Zhao X, Decollogne S, Creighton B, Flynn E, Folkman J, Hogg PJ (2003) A peptide trivalent arsenical inhibits tumor angiogenesis by perturbing mitochondrial function in angiogenic endothelial cells. Cancer Cell 3(5):497–509. https://doi.org/10.1016/S1535-6108(03)00109-0
Matulis SM, Morales AA, Yehiayan L, Croutch C, Gutman D, Cai Y, Lee KP, Boise LH (2009) Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line. Mol Cancer Ther 8(5):1197–1206. https://doi.org/10.1158/1535-7163.MCT-08-1072
Fan XY, Liu YJ, Cai YM, Wang AD, Xia YZ, Hu YJ, Jiang FL, Liu Y (2019) A mitochondria-targeted organic arsenical accelerates mitochondrial metabolic disorder and function injury. Bioorg Med Chem 27(5):760–768. https://doi.org/10.1016/j.bmc.2019.01.008
Liu YJ, Fan XY, Zhang DD, Xia YZ, Hu YJ, Jiang FL, Zhou FL, Liu Y (2020) Dual inhibition of pyruvate dehydrogenase complex and respiratory chain complex induces apoptosis by a mitochondria-targeted fluorescent organic arsenical in vitro and in vivo. ChemMedChem 15(6):552–558. https://doi.org/10.1002/cmdc.201900686
Liu YJ, Fan XY, Wang AD, Xia YZ, Fu WR, Liu JY, Jiang FL, Liu Y (2019) LDHA suppression altering metabolism inhibits tumor progress by an organic arsenical. Int J Mol Sci 20(24):6239–6256. https://doi.org/10.3390/ijms20246239
Zhang D, Liu Y, Luo Z, Chen Y, Xu A, Liang Y, Wu B, Tong X, Liu X, Shen H, Liu L, Wei Y, Zhou H, Liu Y, Zhou F (2019) The novel thioredoxin reductase inhibitor A-Z2 triggers intrinsic apoptosis and shows efficacy in the treatment of acute myeloid leukemia. Free Radic Biol Med 146:275–286. https://doi.org/10.1016/j.freeradbiomed.2019.11.013
Frazier AE, Thorburn DR, Compton AG (2019) Mitochondrial energy generation disorders: genes, mechanisms, and clues to pathology. J Biol Chem 294(14):5386–5395. https://doi.org/10.1074/jbc.R117.809194
Wallace DC, Fan W, Procaccio V (2010) Mitochondrial energetics and therapeutics. Annu Rev Pathol Mech Dis 5(1):297–348. https://doi.org/10.1146/annurev.pathol.4.110807.092314
Eisenberg L, Eisenberg-Bord M, Eisenberg-Lerner A, Sagi-Eisenberg R (2020) Metabolic alterations in the tumor microenvironment and their role in oncogenesis. Cancer Lett 484:65–71. https://doi.org/10.1016/j.canlet.2020.04.016
Chi X, Wang Y, Heng BC, Wei Y, Guo Y, Zhang X, Zhao H, Yin Y, Deng X (2020) Mitochondria transfer enhances proliferation, migration, and osteogenic differentiation of bone marrow mesenchymal stem cell and promotes bone defect healing. Stem Cell Res Ther 11(1):245–260. https://doi.org/10.1186/s13287-020-01704-9
Bock FJ, Tait SWG (2020) Mitochondria as multifaceted regulators of cell death. Nat Rev Mol Cell Biol 21(2):85–100. https://doi.org/10.1038/s41580-019-0173-8
Weidling IW, Swerdlow RH (2020) Mitochondria in Alzheimer’s disease and their potential role in Alzheimer’s proteostasis. Exp Neurol 330:113321–113328. https://doi.org/10.1016/j.expneurol.2020.113321
Martínez-Reyes I, Cardona LR, Kong H, Vasan K, McElroy GS, Werner M, Kihshen H, Reczek CR, Weinberg SE, Gao P, Steinert EM, Piseaux R, Budinger GRS, Chandel NS (2020) Mitochondrial ubiquinol oxidation is necessary for tumour growth. Nature 585:288–292. https://doi.org/10.1038/s41586-020-2475-6
Jovanovski A, Pergolizzi B, Pironi L, Stanga S, Panuzzo C, Fava C, Cilloni D (2020) Mitochondria: a galaxy in the hematopoietic and leukemic stem cell universe. Int J Mol Sci 21(11):3928–3954. https://doi.org/10.3390/ijms21113928
Jimenez-Blasco D, Busquets-Garcia A, Hebert-Chatelain E, Serrat R, Vicente-Gutierrez C, Ioannidou C, Gómez-Sotres P, Lopez-Fabuel I, Resch-Beusher M, Resel E, Arnouil D, Saraswat D, Varilh M, Cannich A, Julio-Kalajzic F, Bonilla-Del Río I, Almeida A, Puente N, Achicallende S, Lopez-Rodriguez M-L, Jollé C, Déglon N, Pellerin L, Josephine C, Bonvento G, Panatier A, Lutz B, Piazza P-V, Guzmán M, Bellocchio L, Bouzier-Sore A-K, Grandes P, Bolaños JP, Marsicano G (2020) Glucose metabolism links astroglial mitochondria to cannabinoid effects. Nature 583:603–608. https://doi.org/10.1038/s41586-020-2470-y
Picard M, Wallace DC, Burelle Y (2016) The rise of mitochondria in medicine. Mitochondrion 30:105–116. https://doi.org/10.1016/j.mito.2016.07.003
Vuda M, Kamath A (2016) Drug induced mitochondrial dysfunction: mechanisms and adverse clinical consequences. Mitochondrion 31:63–74. https://doi.org/10.1016/j.mito.2016.10.005
Feng Q, Kornmann B (2018) Mechanical forces on cellular organelles. J Cell Sci 131(21):218479–218487. https://doi.org/10.1242/jcs.218479
Zhang L, Trushin S, Christensen TA, Bachmeier BV, Gateno B, Schroeder A, Yao J, Itoh K, Sesaki H, Poon WW, Gylys KH, Patterson ER, Parisi JE, Diaz Brinton R, Salisbury JL, Trushina E (2016) Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s disease. Sci Rep 6(1):18725–18736. https://doi.org/10.1038/srep18725
Chen G, Li W, Kepp O, Zhu Y, Ma K, Chen Q (2020) Mitophagy, mitochondrial homeostasis, and cell fate. Front Cell Dev Biol 8:467–480. https://doi.org/10.3389/fcell.2020.00467
Han S, Jeong YY, Sheshadri P, Su X, Cai Q (2020) Mitophagy regulates integrity of mitochondria at synapses and is critical for synaptic maintenance. EMBO Rep 21(9):e49801. https://doi.org/10.15252/embr.201949801
Cogliati S, Enriquez JA, Scorrano L (2016) Mitochondrial cristae: where beauty meets functionality. Trends Biochem Sci 41(3):261–273. https://doi.org/10.1016/j.tibs.2016.01.001
Ru-Zhou Z, Jiang S, Zhang L, Zhi-Bin Y (2019) Mitochondrial electron transport chain, ROS generation and uncoupling (Review). Int J Mol Med 44(2):3–15
Dalla Pozza E, Dando I, Pacchiana R, Liboi E, Scupoli MT, Donadelli M, Palmieri M (2020) Regulation of succinate dehydrogenase and role of succinate in cancer. Semin Cell Dev Biol 98:4–14. https://doi.org/10.1016/j.semcdb.2019.04.013
Pfanner N, Warscheid B, Wiedemann N (2019) Mitochondrial proteins: from biogenesis to functional networks. Nat Rev Mol Cell Biol 20(5):267–284. https://doi.org/10.1038/s41580-018-0092-0
Schgger H, Link TA, Engel WD, Von JG (1986) Isolation of the eleven protein subunits of the bc1 complex from beef heart. Methods Enzymol 126(126):224–237. https://doi.org/10.1016/S0076-6879(86)26024-3
Kadenbach B, Hüttemann M (2015) The subunit composition and function of mammalian cytochrome c oxidase. Mitochondrion 24(1):64–76. https://doi.org/10.1016/j.mito.2015.07.002
Forrest MD (2015) Why cancer cells have a more hyperpolarised mitochondrial membrane potential and emergent prospects for therapy. bioRxiv:025197. https://doi.org/10.1101/025197
Kueh Hao Y, Niethammer P, Mitchison Timothy J (2013) Maintenance of mitochondrial oxygen homeostasis by cosubstrate compensation. Biophys J 104(6):1338–1348. https://doi.org/10.1016/j.bpj.2013.01.030
Waypa GB, Marks JD, Guzy R, Mungai PT, Schriewer J, Dokic D, Schumacker PT (2010) Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ Res 106(3):526–535. https://doi.org/10.1161/CIRCRESAHA.109.206334
Cho H, Cho Y-Y, Shim MS, Lee JY, Lee HS, Kang HC (2020) Mitochondria-targeted drug delivery in cancers. Biochim Biophys Acta Mol Basis Dis 1866(8):165808–165827. https://doi.org/10.1016/j.bbadis.2020.165808
Don AS, Hogg PJ (2004) Mitochondria as cancer drug targets. Trends Mol Med 10(8):372–378. https://doi.org/10.1016/j.molmed.2004.06.005
Acknowledgments
We gratefully acknowledge the financial support of National Natural Science Foundation of China (22073070, 21673166).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Liu, YJ., Liu, Y. (2022). Mitochondrial Toxicity of Organic Arsenicals. In: Tomar, N. (eds) Mitochondria. Methods in Molecular Biology, vol 2497. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2309-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2309-1_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2308-4
Online ISBN: 978-1-0716-2309-1
eBook Packages: Springer Protocols